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1. Introduction 
1.1 Membrane transport and radioisotopes 
In order to function, cells of necessity must transport a variety of substances across their 
plasma membranes. Aside from simple non-polar entities, most of these will require the 
presence of special transport proteins. Radioisotopes, used as tracers for these substrates, 
have provided an invaluable tool for understanding the mechanism and regulation of such 
transport pathways. 
In this chapter, we will cover some theoretical and practical issues concerning the 
measurement of transport with radioactive tracers. As an illustration, we will focus on 
membrane transport in red blood cells, a tissue much used in the study of membrane 
permeability. In particular, we will look at the abnormal cation permeability of red blood 
cells from sickle cell patients to show how radioactive tracer methodologies can be used to 
investigate the pathophysiology of membrane permeability. 
Chemical analysis of transport is feasible, but can often be tedious and slow. That by 
radioactive tracers has the advantage of being relatively immediate whilst retaining 
comparative simplicity. The first artificial radioisotopes were produced by Curie and Juliot 
in 1934 when they synthesised phosphorus-30 by exposure of aluminium-27 to Ǐ particles. 
Over the next 50 years or so, numerous different radioisotopes became available and were 
widely used to follow transport across biological membranes. Seminal examples include the 
use of 24Na+ to investigate active Na+ transport across the giant axon of cuttlefish in the mid 
1950s (Hodgkin & Keynes, 1955a, 1955b; as elegantly retold by Boyd, 2011, following 
Keynes’ death last year). The perceptive analysis of these studies underpinned the 
hypothesis and identification of the Na+/K+ pump by Skou, Post, Jolly and colleagues (Skou, 
1957; Post & Jolly, 1957; Glynn, 2002; Skou, 2003), whilst in the late 1960s onwards Glynn 
and colleagues also used 24Na+ and 42K+ to study the pump (Garrahan & Glynn, 1967) and 
especially the existence of occluded ions (Glynn et al., 1984; Glynn, 2002). 
With more recent methodogical advances and the more restrictive practices surrounding use 
of radioactive compounds, other non-radioactive methods (such as ion-sensitive 
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microelectrodes or fluorophores, patch clamp methodology and molecular methods) have 
overtaken the use of radioactive tracers in popularity. Although the use of radioactive 
isotopes for transport studies has declined, however, they remain a valuable tool. This 
chapter provides a timely opportunity to illustrate their continuing value. 
2. Flux analysis 
2.1 The theory of transport measurement 
The flux of a substance (J, typically given as moles per unit time) can be taken as its rate of 
movement from one defined region to another. Biologically relevant fluxes, of course, 
usually take place across a selective permeability barrier, which is often the cellular plasma 
membrane, or that of an organelle, or perhaps across a whole tissue. (For simplicity, the 
following account will usually refer only to cells but implicit in this term is the whole gamut 
of these other compartments). 
In biology, often the two compartments which lose and accept the substance are the outside 
and inside of cells. As such, rather than measuring flux in units of moles per unit time, it is 
more usual to measure it in terms of cell number or cell volume, with units of moles.(cell 
volume.time)-1 or moles.(cell number.time)-1. 
From Fick’s first law of diffusion, flux will depend on time (t), the concentration difference 
across the barrier (ΔC), the permeability of the barrier (P) to the substrate in question and its 
area (A). One form of Fick’s first law of diffusion therefore is: 
 J = - P. A. ΔC  (1) 
The permeability coefficient, P, with units of distance per unit time (often cm.s-1) is simply 
derived from Einstein’s diffusion coefficient (D). The units of D (often cm2.s-1) are derived 
from the average distance, x, over which a substance diffuses in one dimension per unit 
time, where: 
 2x  2 D. T  (2) 
If we want to know the diffusion co-efficient within the barrier separating the two 
compartments, as well as measuring flux we need to know the concentration of substrate 
within the membrane on each side (and not simply the concentration in aqueous fluid 
bathing the barrier). This requires knowledge of both the partition coefficient (K) and the 
functional thickness of the barrier (d). These are related such that: 
 P  D. K /  d  (3) 
Whilst it is relatively simple to measure the permeability co-efficient, ignorance of the 
partition coefficient and the exact thickness of the major barrier to movement make its 
separation into its three component parts more problematical. 
A further complication arises with highly permeant substrates which move rapidly between 
compartments. Here exact measurement of the time that substrate and barrier are in contact, 
and also the presence of unstirred layers, become important issues. In these cases, 
establising permeabilities accurately will require sophisticated devices for rapid mixing and 
separation of cells and substrate. 
From seminal work in the earlier part of the twentieth century investigating the 
permeability coefficients of substrates using large cells such as the plant algae Chara 
www.intechopen.com
The Use of Radioisotopes to Characterise the  
Abnormal Permeability of Red Blood Cells from Sickle Cell Patients 
 
153 
ceratophylla (Collander, 1949), the membrane of cells was originally considered to be a 
hydrophobic sieve, where transport reflected the lipid solubility and size of the substrate. 
We now know, of course, that many substances use specific protein-mediated pathways for 
their transport. Flux analysis is therefore often used to tell us how rapidly substances cross 
from one side to the other using these more-or-less specific transport systems. By utilising 
different conditions, one can measure the affinity of the protein for its substrate, potential 
inhibitors and their mechanism of action, and factors involved in regulating the activity of 
these protein transport system. 
2.2 Uptake assays 
Uptake studies involve measurement of the rate of entry of a substance into a compartment. 
This may involve a relatively simple procedure to incubate cells and radioactive test 
substance for the requisite amount of time. The ratio of the volume of cells to that of the 
extracellular medium should be low. This serves to limit any change in extracellular 
composition, especially concentration of the test substance during incubation. Afterwards, it 
is then necessary to remove that part of the substance remaining extracellularly.  
An important consideration is prevention of surface binding and any loss, degradation or 
metabolism of the test substance which will artefactually alter the measured value. After 
separating out the cells at the end of incubation, it is also necessary to avoid or account for 
any residual trapped extracellular medium. If thorough separation of target compartment 
and extracellular medium is impractical, impermeable space markers can be added to 
measure accurately the volume of trapped extracellular medium and thereby calculate the 
extent of unincorporated test substance.  
A key property of space markers is to penetrate all the remaining extracellular volume whilst 
being excluded from the compartment under study. Typical ones include inulin, mannitol, 
sucrose, polyethylene glycol (PEG), sorbitol (which can all be labelled with 3H or 14C). 
Alternative commonly used extracellular markers are represented by 51Cr, 57Co, 60Co-labelled 
EDTA, 125I-labelled albumin and various other ions such as 22Na, 24Na, 42K, 86Rb, 35SO4 and 
ethane sulphonate. For organic molecules, it is sometimes useful to employ non-transported 
stereoisomers (eg L-glucose as a space marker for D-glucose; D-alanine for L-alanine).  
If both space marker and substrate are radioactive, their activity must be distinguished 
during counting. There are several ways to expedite this. For example, the space marker 
chosen may have a much shorter half-life than the test substance (ie count sample twice, 
before and after decay of the space marker) or a different type of radioactive emission (ie 
allowing the different energy of emitted particles to be distinguished). A further 
consideration is that the volume of trapped extracellular medium is likely to be small 
relative to target compartment, thus accurate determination of its volume will require a high 
specific activity of space marker relative to test substance. 
2.3 Separation methods 
Following incubation with the radioactive test substance, it is necessary to separate the 
target compartment from unincorporated medium. For larger tissues (tissue slices, whole 
muscles or nerves, etc) this is achieved simply by exchange of radioactive extracellular 
medium with an excess of a non-radioactive stop solution. Smaller target compartments 
require other methods. These are usually represented by washing techniques, oil separation 
methods and filtration techniques. 
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Washing methods are very versatile. High speed (15,000g) bench centrifuges can be used to 
rapidly pellet samples within a few seconds. Supernatant is then aspirated leaving the cell 
pellet. This is a common method for isolated cells such as red cells, lymphocytes, platelets, 
isolated hepatocytes or epithelial cells. For incubations of short duration or for more labile 
substrates, incubations can be terminated by addition of ice-cold wash solutions (to reduce or 
prevent transporter activity) prior to centrifugation. Estimates of the volume of target 
compartment (eg of red cells from the haematocrit) and trapped extracellular medium (usually 
5-20% that of the cells) can be made to determine the number of washes required to dilute 
adequately unincorporated test substance. For example, for red cells at 2-5% haematocrit in 
1ml reaction volume, we find that 4 washes (5 spins) with 1ml wash solution are adequate. In 
this case, volume of cells will be 20-50µl, that of trapped extracellular medium about 2-10µl, 
diluted 100-fold with each wash, ie 108-fold with 4 washes. From the activity of the starting 
reaction medium and the expected rate of incorporation of test substance, it is simple to 
determine whether this will be adequate to interfere with the signal.  
Washing can also be refined by addition of specific inhibitory strategies to limit further 
uptake or loss – ice-cold media, specific chelators (eg EGTA for Ca2+, EDTA for Mg2+), 
transporter inhibitors (eg Ba2+ for K+ channels, phloretin or HgCl2 for glucose transporters, 
nitrobenzylthioinosine for nucleosides) or with “chase” strategies adding excess unlabelled 
solutes (though care must be exercised should exchange-diffusion, ie trans stimulation, be a 
possibility as this will artefactually reduce incorporated solute). 
Oil separation methods may be used for more rapid fluxes where the more protracted 
washing processes may result in unacceptable loss of radioactive tracer. Flux durations as 
short as about 5s are practical with these (cf about 30s for washing methods). The strategy is 
to choose an oil with density greater than that of the incubation medium but less than that of 
the cells. On centrifugation, cells spin out through the oil leaving saline suspended above. 
Diphthalate esters have proved particularly useful. Diethyl, dibutyl and di-iso-octyl 
diphthalates have densities of 1.118, 1.047 and 0.981 g.ml-1, respectively. They can be mixed 
to achieve an appropriate density relative to that of the cell under investigation. An 
appropriate stop solution (often ice-cold) is placed on top of the oil layer, the sample is 
added and tubes rapidly centrifuged to pellet cells through the oil layer. In addition, a third 
layer at the bottom (such as formic acid) may be used to lyse cells quickly and prevent 
intracellular metabolism should this be an issue.  
Using oils, separation of cells and medium is usually less complete than for washing 
techniques. In the case of red blood cells, for example, residual trapped medium is about 2% 
cell volume. Depending on this ratio of cell volume to trapped medium, it may be necessary 
again to add appropriate space markers. It then remains to aspirate the saline and oil and 
carefully clean the inside of the centrifuge tube (with tissue or cotton bud) to remove 
residual tracer adherent to the sides. 
Filtration methods may also be used to separate cells from unincorporated radioactive 
tracer. This involves choosing filters of appropriate pore size to retain the target tissues. A 
range of pore sizes and filter materials are available. Common ones comprise nylon, PVC, 
PTFE, cellulose acetate, methylcellulose, cellulose acetate/nitrate mixtures, polycarbonate 
and glass fibre. For example, nitrocellulose filters of 0.2-0.45µm pore size are suitable for 
many isolated cells. The filter usually rests on a rigid support and unincorporated media 
and a suitable wash solution is sucked through using negative pressure. Potential problems 
involve binding of tracer to the filter (this can be reduced through pre-washing with excess 
cold substrate) or poor trapping of the target tissue (eg small vesicles). In addition, cell lysis 
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during the filtration or subsequent washing can be substantial. Refinements of this 
technique include the use of small chromatography columns which bind free substrate 
whilst allowing the target tissue to pass through. 
2.4 Efflux 
Efflux studies measure the appearance of tracer into the extracellular medium. They have 
certain advantages, but also disadvantages, over uptake methods. Thus in principle, it is 
simpler to obtain cell-free extracellular media, by centrifugation or filtration than it is to 
separate out an uncontaminated cell pellet. The limitations involve initial loading where 
high intracellular specific activity is often required. Other issues include intracellular 
compartmentalisation of tracer, metabolism, surface binding and also kinetic analysis of the 
results. In addition, unstable cells may lyse during incubation or the separation process and, 
containing high specific activity of label, will obviously pose considerable threat of heavy 
extracellular contamination.  
2.5 Kinetic considerations 
Other reviews (such as Schultz, 1980; Stein, 1986) should be consulted for full kinetic 
analysis and only a brief overview is presented here. In general, there are three main 
parameters associated with flux measurements:  uptake or loss over a fixed period of time 
(sometimes referred to as an “influx” or “efflux”), the rate constant (which provides 
information on the initial rate of tracer flux) and the affinity of a substrate with its 
transporter (equivalent to the Michaelis constant, Km, of enzyme systems).  
Influx over a defined duration is the simplest to determine but it is important to establish 
that the flux is linear over this time and does not exhibit saturation.  
If uptake or loss is followed more carefully as a function of time, the initial linear rate will 
decrease following an exponential relationship until intracellular and extracellular 
concentrations become equal, at which point the rate of tracer influx and efflux are the same.  
For uptake:   
  kttC  C . 1 –  e  (4) 
where C gives the radioactivity in the cells at time (Ct) and after equilibration (C∞) and k is 
the rate constant.  
For efflux:   
 ktt 0C  C . e
  (5) 
where Ct is defined as previously and C0 is the internal radioactivity at time zero. Thus 
plotting ln ((C∞ - Ct) / C∞ against t for uptake and ln (Ct / C0) for efflux should give a 
straight line relationship whose slope represents the rate constant, k.  
This analysis assumes zero-trans conditions apply initially, ie that the internal concentration of 
tracer for uptake and the extracellular concentration of tracer for efflux is very low compared 
to that on the opposite side of the membrane. In the presence of non-radioactive trans 
substrate, the linear phase is prolonged as the radioactive tracer is diluted. Complications arise 
when systems carry out exchange of substrates when trans-stimulation can occur. 
The rate constant, k, has dimensions of time-1. It can be converted to a flux by multiplying by 
the concentration of the substrate (units of moles per unit volume per unit time). In addition, 
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the rate constant can be used to derive the apparent permeability, P, by multiplying with the 
ratio of volume to surface area (V / A), with units (as before) usually given as cm.s-1. For 
instance, with human red blood cells typical values for V / A are 3.4 x 10-5. 
Transport involving carrier-mediated systems will typically show saturation. A plot of flux 
against concentration gives a rectangular hyperbola which can be analysed using simple 
Michaelis-Menten kinetics to find an apparent affinity of substrate with transporter. In this 
case: 
  max TJ  J . s /  s  K   (6) 
where J is flux, Jmax the maximal flux, s is concentration and KT the apparent dissociation 
constant (the equivalent of the Michaelis constant, KM).  
Graphical analysis of this relationship is used to linearise the plot. The Lineweaver-Burk 
plot of 1 / J vs 1 / s is well known but is less accurate because it gives large weight to fluxes 
at small concentrations. Better are the Eadie-Hofstee or Woolf plots of (J / s) vs (s) or (J) vs (J 
/ s). 
Often there may be several mechanisms by which substrates cross membranes which 
complicates analysis, as J vs s then represents the sum of several components. The simplest 
case would be a saturable transporter in parallel with a diffusion non-saturable component, 
in which case: 
   max TJ  J . s /  s  K   D. s    (7) 
It is possible, however, to have much more complicated arrangements – such as the 
multiple systems involved in amino acid transport across red cell membranes (Barker & 
Ellory, 1990). 
2.6 Some problems with use of radioisotopes 
One needs to be sure that any radioactive counts actually originate from the substrate under 
consideration and that it is located in the correct site. There are a number of issues here. 
Purity of the radioactive tracer may be a problem, though commercial sources are usually 
reliable. Loss of label from the substrate can occur, however, especially with organic 
molecules containing 3H or 14C or 32P. These groups (especially 3H) may be labile and 
exchange with various targets, notably that of water. That labels remain in the desired 
compounds can be checked using chromatography – especially worthwhile with older 
stocks of radioactive tracers. Ions are usually more stable but can change valency (eg Cr2+, 
Cr3+ and CrO42-) so that again radioactive label is no longer in the requisite substrate. 
Metabolic substances may also be rapidly metabolised by cells and tracer may then be lost 
as by-products (such as 14C as 14CO2, 3H as 3H2O). On the other hand, incorporation of 
substance into other compounds or into subcompartments may give a misleading 
overestimate of intracellular accumulation. Thus amino acids may be synthesised rapidly 
into proteins or glutathione; Ca2+ may be pumped avidly into intracellular stores.  An 
obvious strategy is to use non-metabolisable analogues like 3-O-methylglucose for glucose 
or ATP--S for ATP or to prevent secondary movement of tracer with appropriate inhibitors 
(like thapsigargin for the Ca2+ pump of certain intracellular organelles or vanadate for that 
of the plasma membrane). When counting is carried out, it is also important to account for 
the possibility of quenching. This may occur through contamination of the samples with 
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coloured material or soluble macromolecules and has the effect of shifting the energy 
spectrum to lower values. Channels ratio analysis, or the use of external standards, are 
common ways of dealing with this problem. Finally, it should be realised that flux 
measurement with radioisotopes provides a unidirectional value and does not give any 
information on net flux movements. This will be an important caveat in assessing the 
significance of any results.  
3. Red blood cells and membrane transport 
3.1 Red blood cells as a transport paradigm 
Red blood cells are simple cells, readily obtainable and fairly homogeneous, and also 
lacking intracellular organelles which may complicate flux studies in other tissues. As such, 
they are highly amenable to transport studies. It is not surprising that they have provided an 
invaluable model system for analysis of the physiology of membrane permeability.  
Seminal studies include those of Overton in the early 1900s (Al-Awquati, 1999), and of 
Ponder and Davson around 1940 (Davson & Danielli, 1943; Davson & Ponder, 1938). Later, 
in the 1960s red cells were used by Hoffman and Tosteson to develop the pump-leak model 
of volume regulation (Tosteson & Hoffman, 1960). The stoichiometry of the Na+/K+ pump 
was also established using red blood cells (Post & Jolly, 1957; Garrahan & Glynn, 1967b). 
Latterly, much has been learnt about the kinetics of facilitated transporters and co-/counter-
transporters – for example those of the glucose transporter and the amino acid transporters 
(Barker & Ellory, 1990; Naftalin, 2010).  
In addition to these physiological studies, the permeability characteristics of the red blood 
cell membrane can be important pathologically, as seen for example in haemolytic 
anaemias and hereditary stomatocytoses (Ellory et al., 1998; Stewart, 2003). Here we focus 
on the abnormal permeability exhibited by red cells from patients with sickle cell disease 
(SCD). 
3.2 Sickle cell disease 
SCD is one of the commonest severe inherited disorders (Bunn & Forget, 1986; Steinberg et 
al., 2001). Its first impact on Western medicine dates from the early 1900s when Herrick and 
colleagues working in Chicago described a low cell count and the presence of abnormally 
shaped, elongated red blood cells in a blood smear from a Grenadan dental student, Walter 
Noel (Herrick, 1910). Noel died aged 32 from acute chest syndrome (Serjeant, 2001). Patients, 
however, may present with very heterologous signs and levels of severity. The numerous 
complications divide into two main groups – a chronic regenerative anaemia and acute 
ischaemic episodes. The latter may manifest as pain, organ dysfunction (stroke, retinopathy, 
osteonecrosis, acute chest syndrome, etc) and ultimately early mortality (Steinberg, 1999; 
Nagel & Platt, 2001). Some patients are severely and frequently affected by these 
complications, others much less so, so that in some cases the individual may even be 
unaware that they have the condition. 
The aetiology of SCD, which was established by Pauling over 50 years ago (Pauling et al., 
1949), is well known – the presence of the abnormal haemoglobin HbS in patients’ red blood 
cells, instead of the usual HbA. HbS results from a single amino acid substitution at residue 
6 of the ǐ chain of haemoglobin with valine replacing glutamic acid (Ingram, 1957). The 
resulting loss of a negative charge enabled identification of HbS by electrophoresis (Pauling 
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et al., 1949). The amino acid change usually reflects a single mutation in codon 6 (an adenine 
to thymine alteration, so GAG becomes GTG) (Marotta et al., 1977). About 2/3rd patients are 
homozygous for HbS (HbSS) but 1/3rd are heterozygotes of HbS and HbC (HbSC) (Nagel & 
Steinberg, 2001; Nagel et al., 2003). In addition, there are a few rarer genotypes (such as 
HbS-ǐ thalassaemia or HbS-HbO-Arab) (Steinberg, 2001). 
Although aetiology is clear, how the presence of HbS results in the clinical complications of 
SCD, however, is not. A key feature is the propensity of neighbouring HbS molecules to 
polymerise upon deoxygenation, encouraged through the loss of glutamate’s negative 
charge. Long rods of HbS aggregates distort the red cell shape into the eponymous sickles 
and other bizarre shapes (like holly leaves). The deleterious effect on red blood cell rheology 
(Hebbel et al., 1980;  Eaton & Hofrichter, 1987), together with altered nitric oxide scavenging 
by haemoglobin following intravascular haemolysis (Hebbel, 1991;  Reiter et al., 2002;  
Gladwin et al., 2004;  Kato et al., 2006) and also release of inflammatory cytokines (Setty et 
al., 2008;  Setty & Betal, 2008), are thought to contribute to SCD complications. Our interest 
lies in the involvement in pathogenesis of the abnormal permeability of the red blood cell 
membrane in SCD patients (Joiner, 1993; Ellory et al., 1998; Gibson & Ellory, 2002; Lew & 
Bookchin, 2005). 
3.3 Membrane transport in sickle cell disease 
Human red blood cells have a particularly high Cl- permeability mediated via the anion 
exchanger (AE1) and also as yet unidentified Cl- channels. As such, their membrane 
potential usually reflects the Nernst equilibrium potential for Cl- (rather than that of K+ as in 
many other cell types). By contrast, their permeability to cations is relatively modest. The 
presence of a low capacity Na+/K+ pump is sufficient to carry out volume regulation, 
repelling ions attracted by the fixed intracellular negative charges of (mainly) haemoglobin 
whilst keeping intracellular K+ levels high and Na+ levels low (Tosteson & Hoffman, 1960;  
Ellory & Lew, 1976). A high capacity plasma membrane Ca2+ pump, together with a low 
passive Ca2+ permeability, also serves to keep intracellular Ca2+ at very low values, some 
30nM (Lew et al., 1982).  
The commoner red cell cation transport pathways and their inhibitors are summarised in 
Table 1, listed in a potential order of significance to ion homeostasis in red blood cells from 
SCD patients. All can be distinguished using radioactive isotopes and requisite inhibitors or 
other manoeuvres (such as ion substitutions). There is an important caveat, however, in that 
few inhibitors (aside from the Na+/K+ pump inhibitor, ouabain) are totally specific. In 
addition, channels, as conductive transport systems, are perhaps better suited to 
electrophysiological analysis such as, patch clamp studies. 
HbS-containing red cells (HbS cells) have an abnormally high cation permeability. This was 
first described in the 1950s, in seminal work by Tosteson and colleagues (Tosteson et al., 
1955) who showed that red blood cells from SCD patients lost potassium chloride and 
osmotically obliged water, thereby causing them to shrink. The effect was exacerbated upon 
deoxygenation. Over the subsequent 50 years, the pathways responsible have been well 
investigated. We now know that three systems are particularly implicated (Joiner, 1993; 
Gibson & Ellory, 2002;  Lew & Bookchin, 2005):  the KCl cotransporter  (KCC, likely a mix of 
isoforms KCC1 and KCC3;   Crable et al., 2005), the Gardos channel (KCNN4, IK1;  Ishii et 
al., 1997;  Hoffman et al., 2003) and a deoxygenation-induced “cation” conductance 
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(sometimes termed Psickle;  Joiner et al., 1988;  Joiner et al., 1993; Lew et al., 1997). Despite its 
central role in dehydration, the molecular identity of the latter, unlike the other two, 
remains unknown.  
 
Name Predominant 
substrate(s) 
Inhibitors (IC50) 
K+-Cl- cotransporter 
(KCC) 
K+, Cl- Bumetanide (180μM(KCC1)-
900μM(KCC4))1 
Furosemide (50μM-sheep RBC)2 
DIOA (10μM)3 
Ca2+-activated K+ 
channel (Gardos 
channel) 
K+ Clotrimazole (0.05-0.1μM)4,5 
- Senicapoc (ICA-17043) (0.011μM)6 
Charybdotoxin (0.8nM)7 
Tioconazole (0.3μM)4 
Miconazole (1.5μM)4 
Econazole (1.8μM)4 
Nifedipine8 
Quinine (5μM)9 
Nitrendipine10 
Deoxygenation-
induced cation channel 
(Psickle) 
Na+, K+, Ca2+, 
Mg2+, Li+, Rb+, 
Cs+ 
Stilbene derivatives (partially)11,12,13  
- DIDS 
- SITS 
Dipyridamole14 
Plasma membrane 
Ca2+-ATPase (PMCA, 
Ca2+-pump) 
Ca2+ Vanadate (non-specific) (3μM)15 
Na+/K+-ATPase 
(Na+/K+-pump) 
Na+, K+ Ouabain (1μM)16 
Hydroxyxanthones 
-MB7 (1.6μM)16 
Oligomycin17 
Vanadate (non-specific)18 
Na+-K+-2Cl- 
cotransporter (NKCC) 
Na+, K+, Cl- Bumetanide (~0.3-0.6μM)19 
Furosemide (500μM)20 
Na+/H+ exchanger 
(NHE) 
Na+, H+ Amiloride 
- EIPA (0.8μM)21 
- DMA (0.023μM-rat RBC)22,23 
K+(Na+)/H+ exchanger K+, Na+, H+ Amiloride 
- EIPA24 
Chloroquine (66μM)24 
Quinacrine (81μM)24 
www.intechopen.com
 
Radioisotopes – Applications in Bio-Medical Science 
 
160 
Name Predominant 
substrate(s) 
Inhibitors (IC50) 
Non-selective cation 
channel (NSCC): 
 
Voltage-dependent 
(NSVDC) 
 
 
 
Volume-dependent 
 
 
Oxidation-dependent 
 
Monovalent 
cations: Na+, 
H+, Rb+, NH4+ 
 
Divalent 
cations: Ca2+, 
Mg2+, Ba2+ 
 
 
 
Stilbene derivatives (partially) 
-DIDS25  
Ruthenium red (3.7μM)26    
IAA (480μM)26  
 
Amiloride  
-EIPA (0.6μM)27  
 
Amiloride (partially) 
-EIPA28  
Gd3+ 28 
Magnesium transport: 
 
Na+-dependent: 
2Na+/Mg2+ exchanger 
 
 
Na+-independent: 
Mg2+/H+ exchanger  
 
Mg2+/anion 
cotransporter 
Na+, Mg2+  
 
 
 
Quinidine (50μM)29  
Mn2+ (0.5-1.0mM)29  
Imipramine (25μM)30  
 
DIDS (40μM)31  
SITS (30μM)31  
Amiloride (0.4mM)31  
Table 1 list of abbreviations: DIDS: 4,4'-diisothiocyanatostilbene-2,2'-disulfonate; DIOA: 
(dihydroindoenyl)oxy]alkanoic acid; DMA: 5-(N,N-dimethyl)amiloride; EIPA: 5-(N-ethyl-N-
isopropyl)amiloride; IAA: iodoacetamide; MB7: 3,4,5,6-tetrahydroxyxanthone; SITS: 4-acetamido-4'-
isothiocyanatostilbene-2,2'-disulfonate. 
Table 1 list of references: 1Mercado et al., 2000; 2Lauf, 1984; 3Garay et al., 1988; 4Alvarez et al., 1992; 
5Brugnara et al., 1993; 6Stocker et al., 2003; 7Wolff et al., 1988; 8Kaji, 1990; 9Reichstein & Rothstein, 1981; 
10Ellory et al., 1992; 11Joiner, 1990; 12Ellory et al., 2007; 13Clark & Rossi, 1990; 14Joiner et al., 2001; 15Tiffert 
& Lew, 2001; 16Zhang et al., 2010; 17Sachs, 1980; 18Cantley et al., 1978; 19Russell, 2000; 20Bernhardt et al., 
1987; 21Pedersen et al., 2007; 22Counillon et al., 1993; 23Masereel et al., 2003; 24Weiss et al., 2004; 
25Halperin et al., 1989; 26Bennekou et al., 2004; 27Lang et al., 2003; 28Duranton et al., 2002; 29Feray & 
Garay, 1986; 30Feray & Garay, 1988; 31Gunther & Vormann, 1990. 
Table 1. Principal cation permeability pathways in human red blood cells and their inhibitors 
In HbS cells, KCC is highly active, over-expressed and also shows abnormal regulation 
(Gibson et al., 1998; Su et al., 1999). These features are distinct from the situation in red 
blood cells from normal HbAA individuals (HbA cells). In HbA cells, KCC activity is 
usually modest even in the youngest cell population, whilst it becomes quiescent as cells age 
and is inactive at low O2 tensions (Hall & Ellory, 1986; Gibson et al., 1998). In HbS cells, KCC 
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activity is high and maintained, with unusual features, showing continued activity even in 
the absence of O2 (Brugnara et al., 1986;  Hall & Ellory, 1986;  Ellory et al., 1991;  Gibson et 
al., 1998). The main stimulus is probably reduction in pH from the normal plasma value of 
pH 7.4 to 7 (Brugnara et al., 1986;  Ellory et al., 1989). When active, KCC mediates coupled 
KCl efflux. Regulation involves a cascade of conjugate pairs of protein kinase and 
phosphatase enzymes (Gibson & Ellory, 2003). 
The Gardos channel (Gardos, 1958) is a Ca2+-activated K+ channel, the activity of which 
reflects abnormal Ca2+ homeostasis in red blood cells from sickle cell patients. These cells 
show a high Ca2+ leak and lower active Ca2+ removal. As such, and particularly under 
deoxygenated conditions, the Gardos channel is activated and mediates rapid conductive K+ 
efflux with Cl- following electrically (Etzion et al., 1993;  Lew et al., 1997). Activity begins at 
around 100nM, becoming maximal at a few µM (Bennekou & Christophersen, 2003). 
The third transport system, Psickle, is not seen in normal red blood cells. However, since its 
molecular identity has not yet been established it remains to be established whether it is in 
fact present. Its apparent absence in HbA cells may in fact result from lack of appropriate 
stimuli, such as HbS polymerisation. Psickle in HbS cells is activated by deoxygenation and 
HbS polymerisation (Mohandas et al., 1986; Gibson et al., 2001). It has characteristics of a 
cation channel and, importantly, is permeable to Ca2+. Entry of Ca2+ through Psickle leads to 
activation of the Gardos channel which mediates rapid K+ efflux with Cl- following 
electrically through separate channels. Psickle is especially responsible for the high Ca2+ influx 
and altered Ca2+ homeostasis (Rhoda et al., 1990; Joiner et al., 1995; Lew et al., 1997).  
The three pathways thereby combine to cause KCl loss with oxygen tension playing an 
important role in regulating membrane permeability. There is also a degree of positive 
feedback. For example, KCl loss will lower intracellular [Cl-] resulting in Cl- entry and 
HCO3- loss via the anion exchanger AE1, thereby acidifying the cell and further stimulating 
KCC (Lew et al., 1991).  
The co-operative function of these three transport systems mediates solute loss, with water 
following osmotically, resulting in red blood cell shrinkage. This can be extensive and rapid 
(Bookchin et al., 1991), or alternatively it may result from modest but repeated episodes as 
the red blood cells circulate. Red blood cells generally lack the ability to regain these lost 
solutes and eventually shrinkage will be significant. The consequent elevation in [HbS] 
markedly encourages polymerisation and sickling, as the lag to polymerisation following 
deoxygenation is inversely proportional to a very high power of [HbS] (Eaton & Hofrichter, 
1987). Hence the abnormal cation permeability of HbS cells is a significant feature of disease, 
of importance to pathogenesis. 
All these systems are particularly amenable to study with radioactive tracer techniques 
making these a powerful way of analysing red blood cell behaviour. In the following, we 
show how radioisotopes can be used to follow the activity of these systems and thereby 
investigate the abnormal cation permeability of HbS cells. In vivo conditions are mimicked 
as much as possible. In particular, we use tonometry and gas mixing to replicate the oxygen 
tensions experienced by the red blood cells as they traverse the circulation. Plasma levels of 
important ions, notably K+, Na+, Ca2+ and Mg2+, also mimic in vivo parameters. 
4. Experimental considerations 
4.1 Methodology 
Blood samples: Routine discarded blood samples were acquired from SCD patients of both 
main genotypes (HbSS and HbSC) using EDTA as anticoagulant. Samples are best left 
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refrigerated as whole blood (with plasma) if not wanted immediately. For longer storage, it 
may be appropriate to incorporate additives for sterility. As required, whole blood was 
washed in saline to remove plasma and buffy coat, and red blood cells stored on ice until 
required. Notwithstanding washing, it should be appreciated that contamination of the red 
blood cell fraction with white cells or platelets can occur and may affect results – a particular 
problem when assessing enzymatic activity. 
Salines and inhibitors:  Nitrate-containing MOPS-buffered saline (N-MBS) comprised (in 
mM): NaNO3 145, CaCl2 1.1, MOPS 10, glucose 5, pH 7.4 at 37oC. Cl--containing MBS (Cl-
MBS) had similar composition but with NaCl replacing NaNO3. Wash solution (W-MBS) 
was isotonic MgCl2 solution:  MgCl2 107, MOPS 10, pH 7.4 at 0oC. The buffer chosen, here 
MOPS, usually reflects the temperature of incubation. It should be noted that most buffers 
have a significant temperature dependence (with pH usually declining as temperature 
increases). Phosphate buffer has a particularly low temperature coefficient and is useful if 
studies are being carried out over a temperature range. Here we used nitrate to replace Cl-. 
Other possibilities include methylsulphate, although there is probably no completely inert 
replacer for Cl- (Payne et al., 1990).  Except for the experiment shown in Figure 1, ouabain 
(100µM) and bumetanide (10 µM) were present during all fluxes to inhibit K+ uptake via the 
Na+/K+ pump and Na+-K+-2Cl- cotransporter (NKCC), respectively. Where required, 
clotrimazole (10µM) was added to inhibit the Gardos channel. To analyse red blood cell 
shape, aliquots of cells were placed in saline containing 0.3% glutaraldehyde before 
examination under light microscopy. 
Tonometry: Several of the transport systems found in red blood cells are O2-sensitive (Gibson 
et al., 2000; Gibson & Ellory, 2002). It is therefore important to regulate O2 tension during 
incubation. We used Eschweiler tonometers, coupled to a Wösthoff gas mixing pump to set 
the O2 tension at the requisite level from 150mmHg to 0 (by mixing pre-warmed and 
humified air and N2). Typically, cells were placed in the tonometers at 10-fold the 
haematocrit needed for transport assay and gently equilibrated at the requisite O2 tension. 
They were then diluted 10-fold into test tubes, also pre-equilibrated at the required O2 level. 
Tubes were also gassed during incubation, but not bubbled as this lyses cells. Humidified 
gas is necessary to prevent dehydration of the samples. In addition, to prevent 
condensation, all glassware and tubing should be submerged and kept at the same 
temperature which will usually be 37oC for mammalian red blood cells. 
Radioisotope and measurement of fluxes:  We used uptake to measure transporter activity. 86Rb+ 
was used as a K+ congener, chosen in preference to 42K+ as its half life is longer (about 18 
days cf 12.4 hours). After dilution of the red cell samples into the test tubes, the flux was 
started by addition of 86Rb+ (final activity about 0.05MBq.ml-1) to warm (37oC) cell 
suspensions. We used 86Rb+ in a solution of 150mM KNO3 added at a 1 in 20 dilution to give 
a final extracellular [K+] of 7.5mM. (Adding K+ with 86Rb+ is particularly useful if fluxes are 
carried out at different [K+]s, for example to study the affinity of a transport system to K+.)  
If cold-start is preferred, time taken for suspensions to reach the incubation temperature 
should be taken into account (about 1min for a 1.5ml eppendorf tube). Symmetrical cold-
stop / cold-start protocols are used to allow for this with tubes kept on ice before placing 
them at 37oC, then being returned to ice for 1min before washing. The duration of uptake 
here was 10min - control experiments have established that uptake is linear over this time 
period – and determinations were usually carried out in triplicates. Uptake was stopped by 
diluting aliquots of the cell suspension into ice-cold W-MBS. Unincorporated 86Rb+ was 
www.intechopen.com
The Use of Radioisotopes to Characterise the  
Abnormal Permeability of Red Blood Cells from Sickle Cell Patients 
 
163 
removed by centrifugation (10s at 15,000g), aspiration of supernatant and addition of further 
wash solution (4 washes and 5 spins in total). After each centrifugation step, cells were 
resuspended by gentle vortexing, though it was noticeable that HbS cells become stickier at 
lower O2 tensions. This can be important for trapping extracellular medium. Following the 
final wash, the cell pellet was lysed with Triton X-100 (0.1%) and protein (mainly 
haemoglobin in the case of red blood cells) precipitated with trichloroacetic acid (TCA, 5%). 
A final centrifugation step was used to separate off the clear, colourless supernatant before 
counting. Activity was measured as Čerenkov radiation by liquid scintillation (Packard Tri-
carb 2100TR). 
Incubation conditions:  The test tubes contained transport inhibitors in Cl-MBS or N-MBS as 
required. Na+/K+ pump activity is then given as the ouabain-sensitive K+ uptake, KCC as 
the Cl--dependent K+ uptake, NKCC as the bumetanide-sensitive K+ uptake and Psickle as the 
K+ uptake in the N-MBS in the presence of all 3 inhibitors.  
Flux calculation:  There are several ways of doing this. The general approach is:   
Flux = {(Sample counts - background)/specific activity} x 
 x (60/flux time in min) x (103/final haematocrit) 
(8)
 
where, specific activity is total counts of 86Rb+ per tube/total mmol K+ per tube. The first 
term converts the sample counts to mmol K+; the second converts the time into flux per 
hour; the third converts volume into flux per litre of packed cells. Therefore, flux units 
become mmol K+(l cells.h)-1, i.e. if 50µl
 
86Rb+ in 150 mM KCl are added to final volume of 1 
ml, and standard counts are the counts in every 10µl of this 86Rb+ stock, for a 10min flux:  
Flux = (sample counts – background counts)/(standard counts – background counts) x 
(10x10-6 x 150) x (60/flux time) x 103 x (1/haematocrit as a fraction). Background counts are 
provided by the same volumes of Triton X-100 and TCA used for sample preparation but 
lacking cells. In practice, the standard counts will be very high relative to samples and 
background and it is not necessary to subtract the background from them. 
4.2 Results 
4.2.1 The main cation transport in red blood cells from sickle cell patients 
In the first series of experiments, the activities of the five main K+ transport systems present 
in the membrane of red cells from homozygous (HbSS) SCD patients were established in 
fully oxygenated (100mmHg O2) and fully deoxygenated (0 O2) conditions (Figure 1).  
Na+/K+ pump activity was present at a similar level to that seen in red blood cells from 
normal individuals (Garrahan & Glynn, 1967) and also many other mammals (Shaw, 1955). 
Its activity was unaffected by O2 tension.  
Similarly, NKCC activity was low and showed little change on deoxygenation, 
notwithstanding that it is usually stimulated by low O2 in red blood cells from other species 
(Gibson et al., 2000). Apparent lack of oxygen sensitivity here may be because activity was 
minimal. Residual K+ movement, in nitrate medium in the presence of ouabain, bumetanide 
and clotrimazole, was minimal, indicative of small movement through other transport 
pathways.  
Two other systems, KCC and Gardos channel, by contrast differ markedly from their 
behaviour in normal red blood cells. KCC is usually quiescent in all but the youngest red 
blood cells from normal individuals. Here it can be seen that influx was high. The high K+ 
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content of red blood cells means that this system will mediate KCl loss at about 10-fold 
greater rates (Dunham & Ellory, 1981). On deoxygenation, KCC activity remained at 
substantial levels. Again, this differs with the situation in normal red blood cells.  
The fourth transport system, Psickle, assayed as a Cl- independent K+ flux, is not found in 
normal red blood cells. Figure 1 shows that on dexoygenation, Psickle activity in patient red 
blood cells became activated.  
One of the main actions of Psickle is to allow entry of Ca2+, thereby perturbing the normal 
pump-leak balance and enabling intracellular Ca2+ to accumulate sufficiently to activate the 
Gardos channel. This, too, was apparent. Gardos channel activity was minimal in 
oxygenated cells – the small component probably coming from irreversibly sickled cells. On 
deoxygenation, the Gardos channel was also activated. 
Similar findings were seen in red blood cells from heterozygous (HbSC) patients. Here KCC 
activity was high, cells sickled on deoxygenation and also showed activation of Psickle and 
the Gardos channel. There was one exception, however. Thus although KCC activity was 
high in oxygenated cells, on deoxygenation it became inhibited – by a mean of 86+4%, n=11, 
p<0.05, cf levels in fully oxygenated cells - as seen in red blood cells from normal HbAA 
individuals. 
 
 
Fig. 1. The activity of the five main cation transport systems of human red blood cells were 
measured under fully oxygenated (100mmHg O2;  open histograms) or fully deoxygenated 
(0mmHg O2;  filled histograms) conditions in samples from patients with sickle cell disease. 
Histograms represent means+S.E.M., n=4, with K+ influx given as mmol.(l cells.h)-1. NKCC 
= Na+-K+-2Cl- cotransporter; KCC = K+-Cl- cotransporter;  Psickle = the deoxygenation-
induced cation pathway;  Gardos = Ca2+-activated K+ channel (Gardos channel);  Na/K 
pump = Na+,K+-ATPase. 
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4.2.2 O2 dependence of cation transport in red blood cells from sickle cell patients 
In the second series of experiments, we followed the activity of the three main transport 
systems (KCC, Gardos channel and Psickle) across the physiological range of O2 tensions as 
red blood cells were deoxygenated from arterial O2 tensions down to levels pertaining to 
metabolically active tissues. Results are shown in Figure 2.  
As the red blood cells were deoxygenated, they began to show the sickling shape change. 
Under fully deoxygenated conditions, over 80% of cells showed evidence of sickling. KCC 
activity was high at arterial O2 tensions, started to decrease as cells were deoxygenated but 
then became activated again at the lowest O2 tensions. Both Psickle and Gardos channel 
activity were reduced at the higher O2 tensions and showed maximal activity when cells 
were fully deoxygenated. Changes to these four parameters all became marked at about the 
P50 of O2 saturation of haemoglobin. Activity of the transport systems correlated with the 
sickling shape change and hence HbS polymerisation. 
 
 
Fig. 2. Effect of oxygen tension on sickling and the activity of KCC, Gardos and Psickle 
(defined as in Figure 1) in red blood cells from sickle cell patients. All are given as 
normalised percentages (%) of maximal transport activity or of complete sickling. Symbols 
represent means+S.E.M., n=3. 
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5. Conclusions 
This chapter illustrates the value of using radioactive isotopes for measurement of fluxes 
across biological membranes. It serves to highlight the relative simplicity of these methods. 
This, coupled with the ability to acquire useful information concerning a variety of transport 
systems through use of ion substitutions or inhibitors, make radioisotopes of continuing 
value. We show the abnormal permeability of red blood cells from SCD patients and how it 
is affected by O2 tension. Historically, fluxes across the red blood cell membrane used 
methods such as haemolysis, such that more permeable species result in faster cell lysis. 
More recent methods have included nuclear magnetic resonance, fluorophores and 
electrophysiological approaches. As shown here, radioisotopes nevertheless remain a 
valuable tool for investigating this field. 
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